Clinical Trials Browser

Withdrawn × durvalumab × Lymphoid × Clear all

NCT03241017 2018-04-09

IDA-D

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse

NCT03235869 2018-03-15

Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma

Phase EARLY_PHASE1 Withdrawn

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous